A High-Throughput Splicing Assay Identifies New Classes of Inhibitors of Human and Yeast Spliceosomes
Open Access
- 1 October 2013
- journal article
- research article
- Published by Elsevier in SLAS Discovery
- Vol. 18 (9) , 1110-1120
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- A Quantitative High-Throughput In Vitro Splicing Assay Identifies Inhibitors of Spliceosome CatalysisMolecular and Cellular Biology, 2012
- Psoromic Acid Derivatives: A New Family of Small-Molecule Pre-mRNA Splicing Inhibitors Discovered by a Stage-Specific High-Throughput in Vitro Splicing AssayChemBioChem, 2012
- SomaticSF3B1Mutation in Myelodysplasia with Ring SideroblastsNew England Journal of Medicine, 2011
- The Spliceosome: Design Principles of a Dynamic RNP MachineCell, 2009
- The Biflavonoid Isoginkgetin Is a General Inhibitor of Pre-mRNA SplicingJournal of Biological Chemistry, 2008
- Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNANature Chemical Biology, 2007
- The NCI60 human tumour cell line anticancer drug screenNature Reviews Cancer, 2006
- Identification and H2O2 sensitivity of the major constitutive MAPK phosphatase from rat brainBiochemical and Biophysical Research Communications, 2004
- A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening AssaysSLAS Discovery, 1999
- The role of the mammalian branchpoint sequence in pre-mRNA splicing.Genes & Development, 1988